메뉴 건너뛰기




Volumn 99, Issue 16, 2013, Pages 1154-1155

2012 ESC STEMI guidelines and reperfusion therapy: Evidence-based recommendations, ensuring optimal patient management

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; TENECTEPLASE;

EID: 84880629279     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2013-304498     Document Type: Short Survey
Times cited : (49)

References (5)
  • 1
    • 84880628657 scopus 로고    scopus 로고
    • The divergence between European STEMI guidelines and evidence: A potential threat to optimising reperfusion therapy for patients with ST-elevation myocardial infarction
    • Terkelsen CJ, Pinto DS, Thiele H, et al. The divergence between European STEMI guidelines and evidence: a potential threat to optimising reperfusion therapy for patients with ST-elevation myocardial infarction. Heart 2013;99:1154-6.
    • (2013) Heart , vol.99 , pp. 1154-1156
    • Terkelsen, C.J.1    Pinto, D.S.2    Thiele, H.3
  • 2
    • 84866732231 scopus 로고    scopus 로고
    • ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC)
    • Steg PG, James SK, Atar D, et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC). Eur Heart J 2012;33:2569-619.
    • (2012) Eur Heart J , vol.33 , pp. 2569-2619
    • Steg, P.G.1    James, S.K.2    Atar, D.3
  • 3
    • 0345060917 scopus 로고    scopus 로고
    • Impact of time to treatment on mortality after prehospital fibrinolysis or primary angioplasty: Data from the CAPTIM randomized clinical trial
    • DOI 10.1161/01.CIR.0000103122.10021.F2
    • Steg PG, Bonnefoy E, Chabaud S, et al. Impact of time to treatment on mortality after prehospital fibrinolysis or primary angioplasty: data from the CAPTIM randomizedclinical trial. Circulation 2003;108:2851-6. (Pubitemid 37517811)
    • (2003) Circulation , vol.108 , Issue.23 , pp. 2851-2856
    • Steg, P.G.1    Bonnefoy, E.2    Chabaud, S.3    Lapostolle, F.4    Dubien, P.-Y.5    Cristofini, P.6    Leizorovicz, A.7    Touboul, P.8
  • 5
    • 83155181389 scopus 로고    scopus 로고
    • Benefit of transferring ST-segment-elevation myocardial infarction patients for percutaneous coronary intervention compared with administration of onsite fibrinolytic declines as delays increase
    • Pinto DS, Frederick PD, Chakrabarti AK, et al. Benefit of transferring ST-segment-elevation myocardial infarction patients for percutaneous coronary intervention compared with administration of onsite fibrinolytic declines as delays increase. Circulation 2011;124:2512-21.
    • (2011) Circulation , vol.124 , pp. 2512-2521
    • Pinto, D.S.1    Frederick, P.D.2    Chakrabarti, A.K.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.